Antimicrobial/endotoxin neutralizing polypeptide
A technology for antimicrobial polypeptides, endotoxins, applied in the field of truncated forms, similar ones, endotoxin-neutralizing polypeptides or functional variants thereof, by administering the polypeptides of the present invention together with antimicrobials
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0079] Host defense polypeptides that produce LF in vivo
[0080] LF is unusually resistant to proteolysis (R.D. Brines and J.H. Brock, Biochim. Biophys. Acta 759:229-35 (1983)), and little is known about its processing during inflammation in vivo. Therefore, N-terminal regions present as small (eg <12 kDa) polypeptides in inflamed human tissue were examined. Immunoblots of sputum from individuals with deep bronchial cough and purulent exudates ("pus") obtained from infected human skin were probed with antibodies specific for the N-terminal 17 residue of mature human LF. The N-terminal region of LF was identified as a low molecular weight polypeptide (Mr-6,000-8,000) in all tested secretions. Scanning density comparison of the immunostaining intensity of the sample 6kDa polypeptide with that of the standard indicated that the fragment was present in secretions at 1-10 [mu]M. This N-terminal polypeptide was also detected in human sputum, although not in gingival plaque or hum...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
